MTOR and neoplasm: Activation of the PI3-kinase/Akt/mTOR signalling pathway may be inhibited by rapamycin, which blocks mTOR activation, resulting in the inhibition of tumour growth (see reviews by Faivre et al, 2006; Georgakis and Younes, 2006).